Nanotechnology standards move forward
This article was originally published in Clinica
December 15 is the deadline by which interested parties must respond to the first four new work item proposals that have been put forward by the European standards committee on nanotechnology, CEN/TC 352. The committee will next meet on April 24-25 2007. This committee covers nanotechnology in general, and not just nanomedicine. It is chaired by Dr Trudy Phelps, chair of the CEN Advisory Board for Healthcare Standards (AHBS).
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.